Avadel Pharmaceuticals (AVDL) News Today → Tech GIANT’s Plans to Revolutionize Crypto… (From Crypto 101 Media) (Ad) Free AVDL Stock Alerts $16.25 -1.93 (-10.62%) (As of 05/8/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineAvadel Pharmaceuticals GAAP EPS of -$0.30 misses by $0.29, revenue of $27.18M beats by $1.28Mmsn.com - May 8 at 4:24 PMAvadel Pharmaceuticals (NASDAQ:AVDL) Shares Gap Down to $18.18marketbeat.com - May 8 at 3:54 PMAVDL Stock Earnings: Avadel Pharmaceuticals Misses EPS, Beats Revenue for Q1 2024investorplace.com - May 8 at 1:15 PMAvadel Pharmaceuticals plc: Avadel Pharmaceuticals Provides Corporate Update and Reports First Quarter 2024 Financial Resultsfinanznachrichten.de - May 8 at 11:20 AMAvadel Pharmaceuticals Reports First Quarter 2024 Earnings: Revenue Surpasses Estimates but Net ...finance.yahoo.com - May 8 at 11:20 AMAvadel Pharmaceuticals (NASDAQ:AVDL) Receives Buy Rating from Needham & Company LLCmarketbeat.com - May 8 at 10:12 AMAvadel Pharmaceuticals Provides Corporate Update and Reports First Quarter 2024 Financial Resultsglobenewswire.com - May 8 at 7:00 AMAvadel Pharmaceuticals (AVDL) to Release Quarterly Earnings on Wednesdaymarketbeat.com - May 2 at 10:17 AMAvadel Pharmaceuticals (NASDAQ:AVDL) Reaches New 1-Year High at $18.97marketbeat.com - May 1 at 4:49 PMAvadel Pharmaceuticals to Provide a Corporate Update and Report First Quarter 2024 Financial Results on May 8globenewswire.com - May 1 at 8:00 AMAvadel Pharmaceuticals (NASDAQ:AVDL) Share Price Passes Above 200-Day Moving Average of $14.01americanbankingnews.com - April 30 at 3:12 AMWall Street Analysts Predict a 28.58% Upside in Avadel (AVDL): Here's What You Should Knowfinance.yahoo.com - April 29 at 1:58 PMVivo Capital LLC Sells 124,329 Shares of Avadel Pharmaceuticals plc (NASDAQ:AVDL)marketbeat.com - April 27 at 9:40 PMEuropean Equities Traded in the US as American Depositary Receipts Trend Modestly Higher in Thursday Tradingmsn.com - April 25 at 11:31 AMAvadel Pharmaceuticals plcmoney.usnews.com - April 21 at 12:36 AM106,475 Shares in Avadel Pharmaceuticals plc (NASDAQ:AVDL) Purchased by Investors Asset Management of Georgia Inc. GA ADVmarketbeat.com - April 18 at 2:21 PMAvadel Pharmaceuticals (NASDAQ:AVDL) Shares Down 3.4% marketbeat.com - April 17 at 11:58 AMAvadel Pharmaceuticals (NASDAQ:AVDL) Hits New 1-Year High at $18.08marketbeat.com - April 16 at 2:58 PMAvadel Pharmaceuticals Sees Unusually Large Options Volume (NASDAQ:AVDL)marketbeat.com - April 16 at 10:35 AMAvadel Pharmaceuticals plc (AVDL)finance.yahoo.com - April 16 at 8:54 AMAvadel Pharmaceuticals (NASDAQ:AVDL) Trading 5.9% Higher marketbeat.com - April 15 at 2:49 PMTraders Buy Large Volume of Put Options on Avadel Pharmaceuticals (NASDAQ:AVDL)marketbeat.com - April 11 at 11:37 AMAvadel Pharmaceuticals plc (NASDAQ:AVDL) Is Expected To Breakeven In The Near Futurefinance.yahoo.com - April 11 at 9:53 AMAvadel Pharmaceuticals' (AVDL) "Buy" Rating Reiterated at Needham & Company LLCmarketbeat.com - April 9 at 8:30 AMAvadel Pharmaceuticals (NASDAQ:AVDL) Share Price Passes Above 200-Day Moving Average of $13.24marketbeat.com - April 4 at 3:19 AMAvadel Pharmaceuticals: A Deep Dive Into Lumryz's Once-Nightly Revolutionseekingalpha.com - April 2 at 6:55 AMAvadel Pharmaceuticals to Present at the 23rd Annual Needham Healthcare Conferenceglobenewswire.com - April 1 at 8:00 AMAVDL Apr 2024 15.000 callfinance.yahoo.com - March 17 at 5:23 PMAVDL Apr 2024 25.000 callfinance.yahoo.com - March 16 at 12:50 AMAVDL Apr 2024 10.000 putfinance.yahoo.com - March 16 at 12:50 AMAvadel Pharmaceuticals plc (NASDAQ:AVDL) Sees Significant Growth in Short Interestmarketbeat.com - March 15 at 12:37 PMAvadel Pharmaceuticals plc (NASDAQ:AVDL) Shares Sold by Adage Capital Partners GP L.L.C.marketbeat.com - March 8 at 7:20 AMBuy Rating Affirmed for Avadel Pharmaceuticals Amid Strong Q4 Performance and Promising Growth Prospectsmarkets.businessinsider.com - March 7 at 10:18 AMKennedy Capital Management LLC Acquires 268,704 Shares of Avadel Pharmaceuticals plc (NASDAQ:AVDL)marketbeat.com - March 7 at 8:31 AMAvadel Pharmaceuticals plc (NASDAQ:AVDL) Forecasted to Earn FY2024 Earnings of ($1.02) Per Sharemarketbeat.com - March 7 at 7:37 AMRTW Investments LP Acquires 325,774 Shares of Avadel Pharmaceuticals plc (NASDAQ:AVDL)marketbeat.com - March 6 at 11:00 AMFY2026 EPS Estimates for Avadel Pharmaceuticals plc (NASDAQ:AVDL) Raised by Leerink Partnrsmarketbeat.com - March 6 at 8:32 AMAvadel Pharmaceuticals: Robust Launch Of Lumryz And Eased Litigation Overhangseekingalpha.com - March 5 at 2:00 PMAvadel Pharmaceuticals (NASDAQ:AVDL) Price Target Raised to $22.00 at Craig Hallummarketbeat.com - March 5 at 10:46 AMAvadel Pharmaceuticals price target raised by $2 at Oppenheimer, here's whyrealmoney.thestreet.com - March 5 at 10:42 AMAvadel Pharmaceuticals Analysts Increase Their Forecasts After Q4 Resultsmsn.com - March 5 at 10:42 AMAvadel Pharmaceuticals plc (NASDAQ:AVDL) Q4 2023 Earnings Call Transcriptfinance.yahoo.com - March 5 at 10:42 AMAvadel Pharmaceuticals Issues Statement On Patent Litigationglobenewswire.com - March 4 at 3:37 PMAvadel Pharmaceuticals plc: Avadel Pharmaceuticals Provides Corporate Update and Reports Fourth Quarter and Full Year 2023 Financial Resultsfinanznachrichten.de - March 4 at 10:49 AMAvadel Pharmaceuticals (NASDAQ:AVDL) Posts Earnings Results, Misses Estimates By $0.01 EPSmarketbeat.com - March 4 at 7:05 AMAvadel Pharmaceuticals Provides Corporate Update and Reports Fourth Quarter and Full Year 2023 Financial Resultsglobenewswire.com - March 4 at 6:30 AMAVDL Mar 2024 5.000 putfinance.yahoo.com - March 3 at 5:51 PMAvadel Pharmaceuticals plc (NASDAQ:AVDL) Given Consensus Rating of "Buy" by Brokeragesmarketbeat.com - March 2 at 1:43 AMAvadel Pharmaceuticals Q4 2023 Earnings Previewseekingalpha.com - March 1 at 1:59 PMWith 62% ownership, Avadel Pharmaceuticals plc (NASDAQ:AVDL) boasts of strong institutional backingfinance.yahoo.com - March 1 at 1:59 PM Get Avadel Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for AVDL and its competitors with MarketBeat's FREE daily newsletter. Email Address The Best AI Stock to Own in the World Today is Trading for Just $25 (Ad)“Titan of Tech” Bets Big on Tiny AI Company He’s made as much as 3,250,000% in just three years on companies like Facebook, Airbnb, and PayPal… But our research shows his latest investment could be his most successful venture yet. See how you can invest alongside him AVDL Media Mentions By Week AVDL Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. AVDL News Sentiment▼0.030.36▲Average Medical News Sentiment AVDL News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. AVDL Articles This Week▼102▲AVDL Articles Average Week Get Avadel Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for AVDL and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: SUPN News Today EWTX News Today TARO News Today ZLAB News Today HRMY News Today SDGR News Today CPRX News Today SNDX News Today KURA News Today DAWN News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:AVDL) was last updated on 5/8/2024 by MarketBeat.com Staff From Our PartnersThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySmallcaps DailyTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaAI “wealth window” is closing June 25thParadigm PressThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldHe Is Giving Away BitcoinCrypto Swap ProfitsGold Set to EXPLODE!Gold Safe ExchangeCharles Payne Demystifies OptionsUnstoppable ProsperityShocking: One AI startup's revenue could surge 4,735%Manward Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Avadel Pharmaceuticals plc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
